Gene therapy companies merge

A Montgomery County medical device company specializing in the precision delivery of cell and gene therapies is merging with a British biotechnology company that is developing gene therapies for retinal diseases. Financial terms of the deal involving Orbit Biomedical of Ambler and Gyroscope Therapeutics, which is based near London, are being kept confidential. The combined company will operate under the Gyroscope name and have its U.S. headquarters in Ambler. It will have a total 50 employees…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news